Home Differentiation of pontine infarction by size
Article Open Access

Differentiation of pontine infarction by size

  • Lei Yang , Wei Qin , Yue Li , Shuna Yang , Hua Gu and Wenli Hu EMAIL logo
Published/Copyright: March 8, 2020

Abstract

Purpose

We hypothesized that the current criteria may be unsuitable for lacunar pontine infarctions (LPI) diagnosis and that size criteria may indicate different stroke mechanisms.

Methods

A total of 102 patients with isolated pontine infarctions were divided into a parent artery disease (PAD) and non-PAD groups according to stenosis of basilar artery. Further, 86 patients from the non-PAD group were divided into paramedian pontine infarction (PPI) and LPI groups. Data were collected from the three groups. The “golden” criterion for LPI was established based on the location of the infarction. A receiver operating characteristic (ROC) curve were used to evaluate the optimal cutoff value to use as an LPI diagnostic indicator.

Results

There was a high prevalence of patients with PAD in both asymptomatic carotid atherosclerosis (ACAS) and PPI groups. Patients with PPI had a higher prevalence in diabetes and ACAS than those with LPI. Based upon the ROC curve, the optimal lesion size cutoff value for use as an LPI diagnostic indicator was 11.8 mm.

Conclusions

Diffusion weighted imaging (DWI) cutoff points for predicting LPI may differ from that of the middle cerebral artery territory. The diameter of LPI may also indicate different stroke mechanisms.

1 Introduction

Lacunar infarction is an ischemic infarction of less than 15 mm in diameter located in the territory of the cerebral penetration arteriole. The most common topographies include the lenticular nucleus, thalamus, frontal lobe white matter, pons, basal ganglia, internal capsule and caudate nucleus. Fisher stated that hypertension is a specific etiology of lacunar infarcts, and segmental arterial disorganization and lipohyalinosis are the main pathological changes attributed to hypertension [1, 2].

The criterion of 15 mm lesion size originated from previous autopsy results; however, in an era of magnetic resonance imaging (MRI) technology, the current cutoff size criterion may have to be reconsidered. Sequence studies have also concluded that the 15 mm size criteria may no longer be useful for lacunar infarction [3, 4]. It is also worth noting that the 15 mm criterion for lacunar infarction includes anterior and posterior circulation. However, recent studies that attempted to challenge this standard have only focused on the middle cerebral artery (MCA) territory [3,4].

Isolated pontine infarctions are classified as either paramedian pontine infarctions (PPI) or lacunar pontine infarctions (LPI). It is widely accepted that PPI is caused by the occlusion of basilar perforating branches, whereas LPI is caused by small vessel disease (SVD) [5, 6]. Previous studies [7, 8, 9, 10, 11, 12] have shown that the infarction size of branch atheromatous disease (BAD) is larger in the MCA compared to the SVD; however, a research pertaining to the criterion such as size in the pons is rare. Our previous study revealed that lesion size is a useful method for distinguishing between SVD and BAD in the MCA territory (Figure 1) [13].

Figure 1 Proposed mechanistic model of isolated pontine infarction. (A) Paramedian pontine infarction (PPI) that results from plaque in the parent artery blocking the branch orifice. (B) Paramedian pontine infarction (PPI) that results from a microatheroma in the orifice of the branch. (C) Lacunar pontine infarction (LPI) that results from fibrinoid necrosis or lipohyalinosis of the distal perforating artery.
Figure 1

Proposed mechanistic model of isolated pontine infarction. (A) Paramedian pontine infarction (PPI) that results from plaque in the parent artery blocking the branch orifice. (B) Paramedian pontine infarction (PPI) that results from a microatheroma in the orifice of the branch. (C) Lacunar pontine infarction (LPI) that results from fibrinoid necrosis or lipohyalinosis of the distal perforating artery.

In this study, we aimed to determine whether size cutoff values for predicting lacunar stroke may be different for the anterior and posterior circulation. Further, we hypothesized that the 15 mm size criteria may no longer be useful for lacunar pontine infarction and that different size criteria may indicate different stroke mechanisms.

2 Methods

2.1 Study population

This retrospective study collected data from the records of consecutive patients admitted to the neurology department at the Beijing Chaoyang Hospital between January 2011 and December 2013 who had an isolated pontine infarction on diffusion weighted imaging (DWI).

Patients included in the study met the following criteria: (1) admitted within one week after stroke onset and (2) MRI showed isolated infarction in the pons. Patients with a definite cardioembolic source (e.g., atrial fibrillation, recent myocardial infarction, dilated cardiomyopathy, valvular heart disease, or infectious endocarditis) were excluded.

Ethics Statement: All subjects consented to participate in our study and signed an informed consent to the use of data for research. The design of this study was approved by the Ethics Committee of Beijing Chao-Yang Hospital, Capital Medical University.

2.2 Demographic and clinical assessments

All patients underwent laboratory testing for urea nitrogen (BUN), creatinine (Cr), uric acid (Ur), creatine kinase (CK), glycosylated hemoglobin (HbA1c), blood glucose (Glu), low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), triglycerides (TG) and homocysteine (HCY). In addition, each patient received a cardiac evaluation that included an electrocardiogram and heart ultrasound.

Demographic features and risk factors were recorded, including hypertension (defined as receiving medication for hypertension or having blood pressure >140/90 mm Hg on repeated measurements), diabetes mellitus (defined as receiving medication for diabetes mellitus or diagnosed at discharge), hyperlipidemia (defined as receiving cholesterol-reducing agents or having LDL ≥2.6 mmol/L at the time of admission), current cigarette smoking, history of stroke and history of coronary heart disease (CAD). The National Institutes of Health Stroke Scale (NIHSS) score was measured at the time of admission and discharge.

2.3 MRI protocol and assessment

Brain magnetic resonance imaging (MRI) was performed within one week of onset of infarction, including DWI, fluid-attenuated inversion recovery (coronal) and magnetic resonance angiography (MRA). Brain MRI was performed with a 1.5T scanner (Signa Horizon LX, GE, American) or a 3.0T MR scanner (Siemens, Erlangen, Germany).

PPI was defined as a lesion extending to the anterior surface of the pons, and LPI was defined as a lesion that did not extend to the anterior surface of the pons (Figure 2). Parent artery disease (PAD) was defined as patients having stenosis of basilar artery. Concomitant asymptomatic cerebral arterial atherosclerosis (ACAS), defined as any extracranial and intracranial cerebral artery atherosclerotic disease unrelated to current isolated pontine infarctions, was also assessed. The diameter of the maximally involved infarct level (axial on DWI) was evaluated as a parameter for the size of the infarct.

Figure 2 Paramedian pontine infarct (PPI) and lacunar pontine infarct (LPI) in brain imaging of DWI and MRA image. (A) Axial DWI showing a PPI. (B) MRA showing stenosis of the basilar artery of the same patient as A. (C) Axial DWI showing a PPI. (D) The basilar artery of the same patient as C is normal; (E) Axial DWI showing an LPI. (F) The basilar artery of the same patient as E is normal.
Figure 2

Paramedian pontine infarct (PPI) and lacunar pontine infarct (LPI) in brain imaging of DWI and MRA image. (A) Axial DWI showing a PPI. (B) MRA showing stenosis of the basilar artery of the same patient as A. (C) Axial DWI showing a PPI. (D) The basilar artery of the same patient as C is normal; (E) Axial DWI showing an LPI. (F) The basilar artery of the same patient as E is normal.

2.4 Assessments of WMH

White matter hyperintensity (WMH) was assessed using a scale of periventricular hyperintensity (PVH) and deep white matter hyperintensity (DWMH), according to Fazekas scoring [14]. Two investigators (neurologists) independently reviewed the MRI and MRA images for each patient. In the case of a discrepancy, a third investigator (neuroradiologist) made the final decision.

Patients were then divided into two WMH burden groups based on their Fazekas scores as follows: ‘‘mild group’’, with a PVH/DWMH Fazekas score of 0 or 1, and ‘‘moderate-severe group’’, with a PVH/DWMH Fazekas score of 2 or 3.

2.5 Statistical analysis

Continuous variables with normal distribution are presented as means with standard deviations and were compared using the Independent-Samples T test, whereas variables with non-normal distribution are presented as medians with interquartile ranges and were compared using the Mann-Whitney U test. Categorical variables were compared using the Chi-square test. Receiver operating characteristic (ROC) curves were plotted to determine the optimal infarct size cutoff-points for predicting different types of pontine lacunar infarction. The “golden” criterion for lacunar infarction in the pons is defined as a lesion not extending to the anterior surface of the pons. We assessed discrimination by calculating the area under the ROC curve (AUC). An area of 1 implies a test with perfect sensitivity and specificity, while an area of 0.5 implies that the model’s predictions are no better than chance. Optimal cutoff-points for size were determined by maximizing the Youden index. Statistical analyses were performed using SPSS 20.0 software. P values of < 0.05 were considered statistically significant.

3 Results

3.1 Patient characteristics

During the study period, 102 patients had isolated pontine infarctions (69 males, 33 females) with a mean age of 64.9 ± 10.9 years (range, 41 to 91 years). Risk factors included hypertension in 75 patients (73.5%), diabetes in 49 patients (48%), cigarette smoking in 31 patients (30.4%), alcohol consumption in 41 patients (40.2%) and hyperlipidemia in 21 patients (20.6%). Additionally, 11 patients (10.8%) had histories of coronary heart disease. The median NIHSS score was 3 (interquartile range, 2 to 5). Sixteen patients (15.7%) had PAD and 82 patients (80.4%) had ACAS, while 72 patients (70.6%) had lesions extending to the surface of the pons.

3.2 Characteristics of isolated pontine infarctions according to PAD

Patients with PAD had a high prevalence of ACAS (P < 0.001) and PPI (P < 0.034). Conversely, there were no significant differences in the prevalence of male gender, hyper tension, DM, hyperlipidemia, history of CAD, smoking and alcohol consumption. There were also no significant differences in levels of glucose, CRP, ESR, DD, HCY, FBG, TG, TC and LDL-C (results are not listed).

Table 1

Characteristics due to the presence of parent artery disease (PAD)

Clinical featuresNon-PAD N = 86PAD N = 16P valve
Age, years64.9 ± 10.964.8 ± 9.40.971
Male56 (65.1%)10 (62.5%)1
Hypertension62 (72.1%)13 (81.2%)0.55
Diabetes42 (48.8%)7 (43.8%)0.789
Hyperlipidemia17 (19.8%)4 (25%)0.737
History of CAD9 (10.5%)2 (12.5%)0.682
Smoking28 (32.6%)3 (18.8%)0.379
Alcohol consumption33 (38.4%)8 (50%)0.415
NIHSS (admission)3 (2-5)4 (2-6)0.493
NIHSS (discharge)2 (1-4)4 (1-5)0.345
PPI57 (66.3%)15 (93.8)0.034*
ACAS66 (77.6%)16 (100)0.037*
PVH (Fazekas) ≥ 242 (48.8 %)6 (37.5%)0.43
DWMH (Fazekas) ≥ 222 (25.6%)5 (31.2%)0.758
HbA1c (%)7.6 ± 2.27.4 ± 1.60.706
  1. Notes: Data are presented as mean ± standard deviation, median (interquartile range) or counts (%). CAD, coronary artery atherosclerosis disease; PAD, parent artery disease; PPI, paramedian pontine infarction; NIHSS, National Institutes of Health Stroke Scale; ACAS, asymptomatic cerebral arterial atherosclerosis; PVH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; HbA1c, glycosylated hemoglobin. *P < 0.05.

3.3 Characteristics of isolated pontine infarctions according to lesion type by DWI

Of 86 patients without PAD, 57 patients were PPI and 29 patients were LPI according to DWI. Patients with PPI had a higher prevalence of diabetes mellitus and ACAS than those with LPI. NIHSS scores were also higher in patients with PPI than in those with LPI.

Table 2

Characteristics according to lesion type by DWI in patients with normal basilar artery

Clinical featuresLPI N = 29PPI N = 57P value
Age, years64.2 ± 8.4665.3 ± 120.616
Male21 (72.4%)35 (61.4%)0.348
Hypertension24 (82.8%)38 (66.7%)0.135
Diabetes9 (31%)33 (57.9%)0.023*
Hyperlipidemia8 (27.6%)9 (15.8%)0.253
History of CAD2 (6.9%)7 (12.3%)0.712
Smoking14 (48.3%)14 (24.6%)0.032*
Alcohol consumption14 (48.3%)19 (33.3%)0.241
NIHSS (admission)2 (1–3)4 (3–6)0.002*
NIHSS (discharge)1 (0–2)3 (2–6)0.001*
Size of infarcts7.03 ± 3.6015.68 ± 3.76< 0.001*
ACAS16 (57.1%)50 (87.7)0.002*
PVH (Fazekas) ≥ 215 (51.7 %)27 (47.4%)0.82
DWMH (Fazekas) ≥ 28 (27.6%)14 (24.6%)0.797
  1. Notes: Data are presented as mean ± standard deviation, median (interquartile range) or counts (%). LPI, lacunar pontine infarction; PPI, paramedian pontine infarction; CAD, coronary artery atherosclerosis disease; PAD, parent artery disease; NIHSS, National Institutes of Health Stroke Scale; ACAS, asymptomatic cerebral arterial atherosclerosis; PVH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; HbA1c, glycosylated hemoglobin. *P < 0.05.

3.4 Models for predicting PPI in patients with isolated pontine infarctions

Based on the ROC curve, the optimal lesion size cutoff value to use as an indicator for diagnosis of LPI was projected to be 11.8 mm (Youden index, 0.8038), which yielded a sensitivity of 87.3% and a specificity of 93.1%, with an area under the curve of 0.935 (95% CI 0.878–0.992; Figure 3).

Figure 3 Receiver operating characteristic (ROC) curves evaluating the accuracy of using lesion size in LPI diagnosis.
Figure 3

Receiver operating characteristic (ROC) curves evaluating the accuracy of using lesion size in LPI diagnosis.

4 Discussion

Our study showed that patients with PAD had a high prevalence of PPI (P < 0.034), and patients with PPI had a higher prevalence of diabetes mellitus and ACAS than those with LPI. Moreover, NIHSS scores were higher in patients with PPI than those with LPI. We also determined that PPI was the primary cause of isolated pontine infarction, suggesting that atherosclerotic perforating arterial disease is the most common cause of isolated pontine infarction.

Our findings are consistent with a study that included 67 acute infarcts involving the pons [5], which reported that patients with PPI have a significantly higher frequency of basilar artery stenosis and a worse prognosis than patients with LPI. Our results are also consistent with a study that looked at 101 isolated pontine infarctions [15], which reported that 79.2% of patients was PPI and BAD was the primary cause of IPI.

In 1965, Fisher reported his series of clinicopathological findings that formed the basis of the lacunar hypothesis, which established a relationship between focal symptoms, topography of lesion, etiology and therapy [1, 2, 16]. Hypertension was considered to be a specific etiology of lacunar infarcts, and lipohyalinosis was the main pathological change due to hypertension. Based on autopsy studies [1, 2], the maximal lesion diameter of 15 mm became a key criterion for imaging diagnosis.

In 1989, Caplan [6] proposed “intracranial b ranch atheromatous disease (BAD)” based on 3 autopsied cases with pontine infarcts. BAD was considered to be narrowing or occlusion of the mouth of the branching artery by an atheromatous process different from lipohyalinosis. He believed infarct of the pons extending to the basal surface resulted from BAD, while lacunar infarction in the pons that did not extend to the basal surface was due to lipohyalinosis.

From a pathological point of view SVD, also named hypertensive SVD, is mainly characterized by a loss of smooth muscle cells from the tunica media, deposits of fibro-hyaline material, and narrowing of the lumen and thickening of the vessel wall. This form of the disease is a common and systemic type that also affects the kidneys and retinas and is strongly associated with aging and hypertension [17]. However, pathological documentation of BAD has been rare. Based on a pathologic study of 3 patients, Caplan determined that either the orifices of the perforator artery could be blocked by an atheroma in the trunk, an atheroma could originate in the trunk and extend into the branch (called junctional atheromatous plaques), or microatheromas could arise at the origin of the branch itself [6].

SVD and BAD are difficult to directly visualize in vivo. Therefore, some markers of radiological phenotypes were selected as representatives for SVD, such as small, deep brain infarcts, cerebral white matter lesions, deep brain hemorrhages and cerebral microbleeds [17]. Further, diabetes mellitus, cerebral atherosclerosis and coronary heart disease may represent BAD.

In our study, patients with PAD had a high prevalence of ACAS and PPI. Patients with PPI had a higher prevalence of diabetes mellitus and ACAS than those with LPI. Also, both diabetes and coronary heart disease are more prevalent in patients with large artery atherosclerosis than in those with small vessel disease. Our results support that LPI is more closely related to SVD caused by lipohyalinosis, whereas PPI is more closely related to BAD caused by atherosclerosis.

A deep subcortical infarct in the perforating arterial territory with a diameter less than 15 mm is currently defined as a “lacunar infarct” due to small vessel occlusion. This concept, which is based on limited clinicopathological correlations, has always been controversial. Small (< 15 mm) subcortical infarcts can also be produced by internal carotid artery stenosis, middle cerebral artery (MCA) stenosis, artery-artery embolism or cardiac embolism (CE), while a larger infarct can also occur without evidence of cerebral vascular stenosis or CE.[18, 19]

The 15 mm criterion originated from previous autopsy results reflecting infarcts in the chronic stage, whereas DWI evaluations show acute cytotoxic or vasogenic edema. Therefore, in the era of MRI technology, this criterion should be reconsidered. Some studies [3, 7, 11] attempted to use a 20 mm diameter criterion for lacunar infarct. However, some studies were concerned that relying on an axial dimension of 15–20 mm may not be the best way to classify lacunar infarct [3, 4].

Research from Cho et al. [3] showed that there was no difference in clinical features or risk factors between an MCA stenosis group and an SVD group, or between SVD groups with lesions < 15 mm and ≥ 15 mm. Thus, they concluded that the 15 mm size criterion may no longer be useful for lacunar infarction. Bang et al. [4] found that a significant proportion of clinical MRI lacunae in patients were correlated with underlying non-lacunar mechanisms. Thus, the authors concluded that universal clinical MRI cutoff points for predicting lacunar stroke may not exist and that a grading system, rather than a dichotomizing one, is needed.

Neuroanatomical studies [20, 21] showed that the lenticulostriate arteries can only arise as individual vessels, by the use of common stems or in both ways. A recent pathological study [22] displayed first-order (proximal) to third-order (distal) branching of perforator arteries of the basal ganglia. Further, an MRI study [23] showed that the size of single small subcortical infarctions (SSSI) can be dependent on the branching order of the arteries involved, with first-order branches being associated with the largest infarct dimensions and the size of SSSIs reaching up to 30 mm. According to arterial anatomy, pontine perfusion territories can be categorized into four groups [24]: anteromedial, anterolateral, lateral and posterior. The anteromedial and anterolateral territories are supplied by basilar arterial branches.

We choose patients with isolated pontine infarction as the subject and evaluated infarct diameter cutoff points for predicting PPI or LPI. We also determined the “golden” criterion for lacunar infarction in the pons, which was defined as a lesion that does not extend to the anterior surface of the pons. This was different from previous studies using specific infarct size or lacunar syndrome, and we found that the lesion size is significantly bigger in PPI patients than in those in the LPI group. Based on the ROC curve, the optimal lesion size cutoff value for the diagnosis of PPI was projected to be 11.8 mm, which yielded a sensitivity of 87.3% and a specificity of 93.1%.

It is important for us to differentiate the two pathogeneses of lacunar infarction, small-vessel occlusion and branch atheromatous disease, since prognoses and treatment strategies differ between PPI and LPI. Patients with PPI had poorer prognosis than those with LPI. According to our study, the size of infarcts can help us distinguish different types of lacunar infarction. In the future, neuropathological examination of patients would be important for us to better understand cerebrovascular diseases [25].

Our study also had limitations. Firstly, we could not completely rule out whether isolated pontine infarctions were due to cardiac embolism or artery-to-artery embolism. Secondly, our study was a retrospectively hospital-based, and thus, selection bias was inevitable. Thirdly, basilar arteries were not examined with high-resolution MRI, so we could not exclude the presence of mild atherosclerotic plaques that did not cause significant luminal stenosis. Fourthly, our patients received 1.5 T or 3 T MRI, which may have increased the variability of the WMH assessment.

5 Conclusions

Our study has several novelties compared to previous studies. First, we proposed that clinical studies on lacunar infarction should separate the two blood supply regions. In addition, our research regarding lacunar infarction focused on the pons, which is different from the previous studies focusing on the territory of MCA. Lastly, in our study, we chose the “golden” criterion for location of infarction (extending or not to surface of pons), which differs from previous studies using specific infarct size or lacunar syndrome. DWI cutoff points for predicting lacunar stroke of pons may differ from territory of MCA.


Phone: +86 13552983366

Acknowledgement

This study was supported by grants from the National Natural Science Foundation of China (No.81271309).

  1. Disclosures: The authors declare that no conflict of interest exists.

References

[1] Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32(8):871-87610.1212/WNL.32.8.871Search in Google Scholar PubMed

[2] Fisher CM. Lacunes: Small, Deep Cerebral Infarcts. Neurology. 1965;15:774-78410.1212/WNL.15.8.774Search in Google Scholar PubMed

[3] Cho AH, Kang DW, Kwon SU, Kim JS. Is 15 mm size criterion for lacunar infarction still valid? A study on strictly subcortical middle cerebral artery territory infarction using diffusion-weighted MRI. Cerebrovascular Diseases. 2007;23(1):14-1910.1159/000095753Search in Google Scholar PubMed

[4] Bang OY, Yeo SH, Yoon JH, Seok JI, Sheen SS, Yoon SR, et al. Clinical MRI cutoff points for predicting lacunar stroke may not exist: need for a grading rather than a dichotomizing system. Cerebrovascular diseases (Basel, Switzerland). 2007;24(6):520-52910.1159/000110422Search in Google Scholar PubMed

[5] Erro ME, Gallego J, Herrera M, Bermejo B. Isolated pontine infarcts: etiopathogenic mechanisms. European Journal Of Neurology. 2005;12(12):984-98810.1111/j.1468-1331.2005.01119.xSearch in Google Scholar PubMed

[6] Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39(9):1246-125010.1212/WNL.39.9.1246Search in Google Scholar PubMed

[7] Zhang CQ, Wang YL, Zhao XQ, Wang D, Liu LP, Wang CX, et al. Distal Single Subcortical Infarction Had a Better Clinical Outcome Compared With Proximal Single Subcortical Infarction. Stroke; a journal of cerebral circulation. 2014;45(9):2613-+10.1161/STROKEAHA.114.005634Search in Google Scholar PubMed

[8] Kim BJ, Lee DH, Kang DW, Kwon SU, Kim JS. Branching Patterns Determine the Size of Single Subcortical Infarctions. Stroke; a journal of cerebral circulation. 2014;45(5):1485-148710.1161/STROKEAHA.114.004720Search in Google Scholar PubMed

[9] Yamamoto Y, Ohara T, Hamanaka M, Hosomi A, Tamura A, Akiguchi I. Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits. Journal of the neurological sciences. 2011;304(1-2):78-8210.1016/j.jns.2011.02.006Search in Google Scholar PubMed

[10] Yamamoto Y, Ohara T, Hamanaka M, Hosomi A, Tamura A, Akiguchi I, et al. Predictive factors for progressive motor deficits in penetrating artery infarctions in two different arterial territories. Journal of the neurological sciences. 2010;288(1-2):170-17410.1016/j.jns.2009.08.065Search in Google Scholar PubMed

[11] Nah HW, Kang DW, Kwon SU, Kim JS. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke; a journal of cerebral circulation. 2010;41(12):2822-282710.1161/STROKEAHA.110.599464Search in Google Scholar PubMed

[12] Cho HJ, Roh HG, Moon WJ, Kim HY. Perforator territory infarction in the lenticulostriate arterial territory: mechanisms and lesion patterns based on the axial location. European neurology. 2010;63(2):107-11510.1159/000276401Search in Google Scholar PubMed

[13] Yang L, Qin W, Zhang X, Li Y, Gu H, Hu W. Infarct Size May Distinguish the Pathogenesis of Lacunar Infarction of the Middle Cerebral Artery Territory. Medical science monitor : international medical journal of experimental and clinical research. 2016;22:211-21810.12659/MSM.896898Search in Google Scholar PubMed PubMed Central

[14] Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR American journal of roentgenology. 1987;149(2):351-35610.2214/ajr.149.2.351Search in Google Scholar PubMed

[15] Ju Y, Hussain M, Asmaro K, Zhao XQ, Liu LP, Li JJ, et al. Clinical and imaging characteristics of isolated pontine infarcts: a one-year follow-up study. Neurological Research. 2013;35(5):498-50410.1179/1743132813Y.0000000207Search in Google Scholar PubMed

[16] Fisher CM, Caplan LR. Basilar artery branch occlusion: a cause of pontine infarction. Neurology. 1971;21(9):900-90510.1212/WNL.21.9.900Search in Google Scholar

[17] Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology. 2010;9(7):689-70110.1016/S1474-4422(10)70104-6Search in Google Scholar PubMed

[18] Futrell N. Lacunar infarction: embolism is the key. Stroke; a journal of cerebral circulation. 2004;35(7):1778-177910.1161/01.STR.0000131930.41057.48Search in Google Scholar PubMed

[19] Bang OY, Heo JH, Kim JY, Park JH, Huh K. Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol. 2002;59(2):259-26310.1001/archneur.59.2.259Search in Google Scholar PubMed

[20] Djulejic V, Marinkovic S, Malikovic A, Jovanovic I, Djordjevic D, Cetkovic M, et al. Morphometric analysis, region of supply and microanatomy of the lenticulostriate arteries and their clinical significance. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2012;19(10):1416-142110.1016/j.jocn.2011.10.025Search in Google Scholar PubMed

[21] Marinkovic SV, Milisavljevic MM, Kovacevic MS, Stevic ZD. Perforating branches of the middle cerebral artery. Microanatomy and clinical significance of their intracerebral segments. Stroke; a journal of cerebral circulation. 1985;16(6):1022-102910.1161/01.STR.16.6.1022Search in Google Scholar

[22] Feekes JA, Hsu SW, Chaloupka JC, Cassell MD. Tertiary microvascular territories define lacunar infarcts in the basal ganglia. Annals of neurology. 2005;58(1):18-3010.1002/ana.20505Search in Google Scholar PubMed

[23] Phan TG, van der Voort S, Beare R, Ma H, Clissold B, Holt M, et al. Dimensions of subcortical infarcts associated with first- to third-order branches of the basal ganglia arteries. Cerebro-vascular diseases (Basel, Switzerland). 2013;35(3):262-26710.1159/000348310Search in Google Scholar PubMed

[24] Kobayashi J, Ohara T, Minematsu K, Nagatsuka K, Toyoda K. Etiological mechanisms of isolated pontine infarcts based on arterial territory involvement. Journal of the neurological sciences. 2014;339(1-2):113-11710.1016/j.jns.2014.01.039Search in Google Scholar PubMed

[25] Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Experimental gerontology. 2012;47(11):825-83310.1016/j.exger.2012.06.001Search in Google Scholar PubMed

Received: 2015-12-01
Accepted: 2020-01-06
Published Online: 2020-03-08

© 2020 Lei Yang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Article
  2. MicroRNA-451b participates in coronary heart disease by targeting VEGFA
  3. Case Report
  4. A combination therapy for Kawasaki disease with severe complications: a case report
  5. Vitamin E for prevention of biofilm-caused Healthcare-associated infections
  6. Research Article
  7. Differential diagnosis: retroperitoneal fibrosis and oncological diseases
  8. Optimization of the Convolutional Neural Networks for Automatic Detection of Skin Cancer
  9. NEAT1 promotes LPS-induced inflammatory injury in macrophages by regulating miR-17-5p/TLR4
  10. Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
  11. Effects of extracorporeal magnetic stimulation in fecal incontinence
  12. Case Report
  13. Mixed germ cell tumor of the endometrium: a case report and literature review
  14. Bowel perforation after ventriculoperitoneal-shunt placement: case report and review of the literature
  15. Research Article
  16. Prognostic value of lncRNA HOTAIR in colorectal cancer : a meta-analysis
  17. Case Report
  18. Treatment of insulinomas by laparoscopic radiofrequency ablation: case reports and literature review
  19. Research Article
  20. The characteristics and nomogram for primary lung papillary adenocarcinoma
  21. Undiagnosed pheochromocytoma presenting as a pancreatic tumor: A case report
  22. Bioinformatics Analysis of the Expression of ATP binding cassette subfamily C member 3 (ABCC3) in Human Glioma
  23. Diagnostic value of recombinant heparin-binding hemagglutinin adhesin protein in spinal tuberculosis
  24. Primary cutaneous DLBCL non-GCB type: challenges of a rare case
  25. LINC00152 knock-down suppresses esophageal cancer by EGFR signaling pathway
  26. Case Report
  27. Life-threatening anaemia in patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
  28. Research Article
  29. QTc interval predicts disturbed circadian blood pressure variation
  30. Shoulder ultrasound in the diagnosis of the suprascapular neuropathy in athletes
  31. The number of negative lymph nodes is positively associated with survival in esophageal squamous cell carcinoma patients in China
  32. Differentiation of pontine infarction by size
  33. RAF1 expression is correlated with HAF, a parameter of liver computed tomographic perfusion, and may predict the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients
  34. LncRNA ZEB1-AS1 regulates colorectal cancer cells by miR-205/YAP1 axis
  35. Tissue coagulation in laser hemorrhoidoplasty – an experimental study
  36. Classification of pathological types of lung cancer from CT images by deep residual neural networks with transfer learning strategy
  37. Enhanced Recovery after Surgery for Lung Cancer Patients
  38. Case Report
  39. Streptococcus pneumoniae-associated thrombotic microangiopathy in an immunosuppressed adult
  40. Research Article
  41. The characterization of Enterococcus genus: resistance mechanisms and inflammatory bowel disease
  42. Case Report
  43. Inflammatory fibroid polyp: an unusual cause of abdominal pain in the upper gastrointestinal tract A case report
  44. Research Article
  45. microRNA-204-5p participates in atherosclerosis via targeting MMP-9
  46. LncRNA LINC00152 promotes laryngeal cancer progression by sponging miR-613
  47. Can keratin scaffolds be used for creating three-dimensional cell cultures?
  48. miRNA-186 improves sepsis induced renal injury via PTEN/PI3K/AKT/P53 pathway
  49. Case Report
  50. Delayed bowel perforation after routine distal loopogram prior to ileostomy closure
  51. Research Article
  52. Diagnostic accuracy of MALDI-TOF mass spectrometry for the direct identification of clinical pathogens from urine
  53. The R219K polymorphism of the ATP binding cassette subfamily A member 1 gene and susceptibility to ischemic stroke in Chinese population
  54. miR-92 regulates the proliferation, migration, invasion and apoptosis of glioma cells by targeting neogenin
  55. Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma
  56. NF2 inhibits proliferation and cancer stemness in breast cancer
  57. Body composition indices and cardiovascular risk in type 2 diabetes. CV biomarkers are not related to body composition
  58. S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53
  59. Review Article
  60. Focus on localized laryngeal amyloidosis: management of five cases
  61. Research Article
  62. NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p
  63. Pericentric inversion in chromosome 1 and male infertility
  64. Increased atherogenic index in the general hearing loss population
  65. Prognostic role of SIRT6 in gastrointestinal cancers: a meta-analysis
  66. The complexity of molecular processes in osteoarthritis of the knee joint
  67. Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
  68. Case Report
  69. Severe anaphylactic reaction to cisatracurium during anesthesia with cross-reactivity to atracurium
  70. Research Article
  71. Rehabilitation training improves nerve injuries by affecting Notch1 and SYN
  72. Case Report
  73. Myocardial amyloidosis following multiple myeloma in a 38-year-old female patient: A case report
  74. Research Article
  75. Identification of the hub genes RUNX2 and FN1 in gastric cancer
  76. miR-101-3p sensitizes non-small cell lung cancer cells to irradiation
  77. Distinct functions and prognostic values of RORs in gastric cancer
  78. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy
  79. Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
  80. Review Article
  81. The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
  82. Research Article
  83. Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma
  84. miR-30a-3p participates in the development of asthma by targeting CCR3
  85. microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9
  86. Bladder-embedded ectopic intrauterine device with calculus
  87. Case Report
  88. Mycobacterial identification on homogenised biopsy facilitates the early diagnosis and treatment of laryngeal tuberculosis
  89. Research Article
  90. The will of young minors in the terminal stage of sickness: A case report
  91. Extended perfusion protocol for MS lesion quantification
  92. Identification of four genes associated with cutaneous metastatic melanoma
  93. Case Report
  94. Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report
  95. Research Article
  96. Voluntary exercise and cardiac remodeling in a myocardial infarction model
  97. Electromyography as an intraoperative test to assess the quality of nerve anastomosis – experimental study on rats
  98. Case Report
  99. CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China
  100. Commentary
  101. Directed differentiation into insulin-producing cells using microRNA manipulation
  102. Research Article
  103. Culture-negative infective endocarditis (CNIE): impact on postoperative mortality
  104. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome
  105. Plasma microRNAs in human left ventricular reverse remodelling
  106. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
  107. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  108. Problems and solutions of personal protective equipment doffing in COVID-19
  109. Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients
  110. Review Article
  111. Gastroenterological complications in kidney transplant patients
  112. Research Article
  113. CXCL13 concentration in latent syphilis patients with treatment failure
  114. A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction
  115. Case Report
  116. Clinicopathological analysis of composite lymphoma: A two-case report and literature review
  117. Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
  118. Research Article
  119. Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
  120. CCTs as new biomarkers for the prognosis of head and neck squamous cancer
  121. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
  122. 72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter
  123. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
  124. Case Report
  125. Total parenteral nutrition-induced Wernicke’s encephalopathy after oncologic gastrointestinal surgery
  126. Research Article
  127. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment
  128. Case Report
  129. Combination of chest CT and clinical features for diagnosis of 2019 novel coronavirus pneumonia
  130. Research Article
  131. Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO
  132. Review Article
  133. Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review
  134. Research Article
  135. Voltage-dependent anion channels mediated apoptosis in refractory epilepsy
  136. Prognostic factors in stage I gastric cancer: A retrospective analysis
  137. Circulating irisin is linked to bone mineral density in geriatric Chinese men
  138. Case Report
  139. A family study of congenital dysfibrinogenemia caused by a novel mutation in the FGA gene: A case report
  140. Research Article
  141. CBCT for estimation of the cemento-enamel junction and crestal bone of anterior teeth
  142. Case Report
  143. Successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: A sequential 25-case series
  144. Research Article
  145. Influence factors of extra-articular manifestations in rheumatoid arthritis
  146. Assessment of knowledge of use of electronic cigarette and its harmful effects among young adults
  147. Predictive factors of progression to severe COVID-19
  148. Procedural sedation and analgesia for percutaneous trans-hepatic biliary drainage: Randomized clinical trial for comparison of two different concepts
  149. Acute chemoradiotherapy toxicity in cervical cancer patients
  150. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse
  151. NANOG regulates the proliferation of PCSCs via the TGF-β1/SMAD pathway
  152. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma
  153. Computer-aided diagnosis of skin cancer based on soft computing techniques
  154. MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B
  155. miR-300/FA2H affects gastric cancer cell proliferation and apoptosis
  156. Hybrid treatment of fibroadipose vascular anomaly: A case report
  157. Surgical treatment for common hepatic aneurysm. Original one-step technique
  158. Neuropsychiatric symptoms, quality of life and caregivers’ burden in dementia
  159. Predictor of postoperative dyspnea for Pierre Robin Sequence infants
  160. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p
  161. Analysis of expression and prognosis of KLK7 in ovarian cancer
  162. Circular RNA circ_SETD2 represses breast cancer progression via modulating the miR-155-5p/SCUBE2 axis
  163. Glial cell induced neural differentiation of bone marrow stromal cells
  164. Case Report
  165. Moraxella lacunata infection accompanied by acute glomerulonephritis
  166. Research Article
  167. Diagnosis of complication in lung transplantation by TBLB + ROSE + mNGS
  168. Case Report
  169. Endometrial cancer in a renal transplant recipient: A case report
  170. Research Article
  171. Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
  172. Case Report
  173. Splenic abscess caused by Streptococcus anginosus bacteremia secondary to urinary tract infection: a case report and literature review
  174. Research Article
  175. Advances in the role of miRNAs in the occurrence and development of osteosarcoma
  176. Rheumatoid arthritis increases the risk of pleural empyema
  177. Effect of miRNA-200b on the proliferation and apoptosis of cervical cancer cells by targeting RhoA
  178. LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis
  179. Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
  180. Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
  181. Case Report
  182. A case of SLE with COVID-19 and multiple infections
  183. Research Article
  184. Circular RNA hsa_circ_0007121 regulates proliferation, migration, invasion, and epithelial–mesenchymal transition of trophoblast cells by miR-182-5p/PGF axis in preeclampsia
  185. SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
  186. Case Report
  187. A case report of cervical pregnancy after in vitro fertilization complicated by tuberculosis and a literature review
  188. Review Article
  189. Serrated lesions of the colon and rectum: Emergent epidemiological data and molecular pathways
  190. Research Article
  191. Biological properties and therapeutic effects of plant-derived nanovesicles
  192. Case Report
  193. Clinical characterization of chromosome 5q21.1–21.3 microduplication: A case report
  194. Research Article
  195. Serum calcium levels correlates with coronary artery disease outcomes
  196. Rapunzel syndrome with cholangitis and pancreatitis – A rare case report
  197. Review Article
  198. A review of current progress in triple-negative breast cancer therapy
  199. Case Report
  200. Peritoneal-cutaneous fistula successfully treated at home: A case report and literature review
  201. Research Article
  202. Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma
  203. Degradation of connexin 50 protein causes waterclefts in human lens
  204. GABRD promotes progression and predicts poor prognosis in colorectal cancer
  205. The lncRNA UBE2R2-AS1 suppresses cervical cancer cell growth in vitro
  206. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells
  207. MicroRNA-182-5p relieves murine allergic rhinitis via TLR4/NF-κB pathway
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2020-0025/html?lang=en&srsltid=AfmBOoqLr466qwRXFShMLZc9TzyDAENtWDJwKZ5xeBdh9uZGTlNjBwiO
Scroll to top button